98 related articles for article (PubMed ID: 38460517)
1. PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer.
Nguyen CDK; Colón-Emeric BA; Murakami S; Shujath MNY; Yi C
Cell Rep; 2024 May; 43(5):114176. PubMed ID: 38691454
[TBL] [Abstract][Full Text] [Related]
2. BRD9-SMAD2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma.
Feng Y; Cai L; Pook M; Liu F; Chang CH; Mouti MA; Nibhani R; Militi S; Dunford J; Philpott M; Fan Y; Fan GC; Liu Q; Qi J; Wang C; Hong W; Morgan H; Wang M; Sadayappan S; Jegga AG; Oppermann U; Wang Y; Huang W; Jiang L; Pauklin S
Gastroenterology; 2024 Jan; 166(1):139-154. PubMed ID: 37739089
[TBL] [Abstract][Full Text] [Related]
3. Protein Arginine Methyltransferases in Pancreatic Ductal Adenocarcinoma: New Molecular Targets for Therapy.
Bhandari K; Ding WQ
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612768
[TBL] [Abstract][Full Text] [Related]
4. Roles of protein arginine methyltransferase 1 (PRMT1) in brain development and disease.
Hashimoto M; Fukamizu A; Nakagawa T; Kizuka Y
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129776. PubMed ID: 33127433
[TBL] [Abstract][Full Text] [Related]
5. PRMT1 promotes pancreatic cancer development and resistance to chemotherapy.
Ku B; Eisenbarth D; Baek S; Jeong TK; Kang JG; Hwang D; Noh MG; Choi C; Choi S; Seol T; Kim H; Kim YH; Woo SM; Kong SY; Lim DS
Cell Rep Med; 2024 Mar; 5(3):101461. PubMed ID: 38460517
[TBL] [Abstract][Full Text] [Related]
6. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W
Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395
[TBL] [Abstract][Full Text] [Related]
7. PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma.
Giuliani V; Miller MA; Liu CY; Hartono SR; Class CA; Bristow CA; Suzuki E; Sanz LA; Gao G; Gay JP; Feng N; Rose JL; Tomihara H; Daniele JR; Peoples MD; Bardenhagen JP; Geck Do MK; Chang QE; Vangamudi B; Vellano C; Ying H; Deem AK; Do KA; Genovese G; Marszalek JR; Kovacs JJ; Kim M; Fleming JB; Guccione E; Viale A; Maitra A; Emilia Di Francesco M; Yap TA; Jones P; Draetta G; Carugo A; Chedin F; Heffernan TP
Nat Commun; 2021 Jul; 12(1):4626. PubMed ID: 34330913
[TBL] [Abstract][Full Text] [Related]
8. Methylation of HSP70 Orchestrates Its Binding to and Stabilization of BCL2 mRNA and Renders Pancreatic Cancer Cells Resistant to Therapeutics.
Wang L; Jia Z; Xie D; Zhao T; Tan Z; Zhang S; Kong F; Wei D; Xie K
Cancer Res; 2020 Oct; 80(20):4500-4513. PubMed ID: 32699135
[TBL] [Abstract][Full Text] [Related]
9. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
[TBL] [Abstract][Full Text] [Related]
10. PRMT1 promotes the tumor suppressor function of p14
Repenning A; Happel D; Bouchard C; Meixner M; Verel-Yilmaz Y; Raifer H; Holembowski L; Krause E; Kremmer E; Feederle R; Keber CU; Lohoff M; Slater EP; Bartsch DK; Bauer UM
EMBO J; 2021 Jul; 40(13):e106777. PubMed ID: 33999432
[TBL] [Abstract][Full Text] [Related]
11. Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients.
Choi W; Kim YH; Woo SM; Yu Y; Lee MR; Lee WJ; Chun JW; Sim SH; Chae H; Shim H; Lee KS; Kong SY
Cancer Res Treat; 2023 Oct; 55(4):1077-1086. PubMed ID: 37309112
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis.
Burdziak C; Alonso-Curbelo D; Walle T; Reyes J; Barriga FM; Haviv D; Xie Y; Zhao Z; Zhao CJ; Chen HA; Chaudhary O; Masilionis I; Choo ZN; Gao V; Luan W; Wuest A; Ho YJ; Wei Y; Quail DF; Koche R; Mazutis L; Chaligné R; Nawy T; Lowe SW; Pe'er D
Science; 2023 May; 380(6645):eadd5327. PubMed ID: 37167403
[TBL] [Abstract][Full Text] [Related]
13. CDK5-PRMT1-WDR24 signaling cascade promotes mTORC1 signaling and tumor growth.
Yin S; Liu L; Ball LE; Wang Y; Bedford MT; Duncan SA; Wang H; Gan W
Cell Rep; 2023 Apr; 42(4):112316. PubMed ID: 36995937
[TBL] [Abstract][Full Text] [Related]
14. Chromatin accessibility profiling by ATAC-seq.
Grandi FC; Modi H; Kampman L; Corces MR
Nat Protoc; 2022 Jun; 17(6):1518-1552. PubMed ID: 35478247
[TBL] [Abstract][Full Text] [Related]
15. Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate pancreatic cancer.
Li Y; He Y; Peng J; Su Z; Li Z; Zhang B; Ma J; Zhuo M; Zou D; Liu X; Liu X; Wang W; Huang D; Xu M; Wang J; Deng H; Xue J; Xie W; Lan X; Chen M; Zhao Y; Wu W; David CJ
Nat Cancer; 2021 Jan; 2(1):49-65. PubMed ID: 35121887
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
